Meet Our Team

Rebecca Gwilt

Co-Founder & Managing Partner
Connect on LinkedIn 

Rebecca Gwilt launched Elevare Law to redefine legal partnerships for healthcare and technology innovators. With over a decade of experience advising pioneering digital health, AI, and virtual care companies, she blends deep regulatory expertise with a future-driven, business-first approach. From launch to exit, Rebecca provides strategic legal counsel that removes friction, mitigates risk, and accelerates growth.

Rebecca co-founded and led the country's first boutique healthcare innovation law firm for over a decade, guiding hundreds of companies through complex regulatory landscapes, helping them pivot, scale, innovate, and succeed. Prior to private practice, she worked with the U.S. Department of Health and Human Services (HHS) on the implementation of the Affordable Care Act and served as National Healthcare Policy Advisor at CGI, a global leader in health reform technology. These experiences shaped her commitment to legal counsel that is practical, proactive, policy-informed, and aligned with each client’s vision, budget, and goals.

At Elevare, Rebecca partners with healthcare visionaries, helping them anticipate challenges, seize opportunities, and build lasting impact. She believes legal should be more than risk management—it should be a catalyst for transformation.

Rebecca is also a passionate advocate for BIPOC and female founders, advising early stage companies, and mentoring startups through accelerators like Plug and Play, Texas Medical Center Innovations, and TechStars. A seeker of joy, investor in underestimated founders, karaoke samurai, expat adventurer, and kindness enthusiast, she lives in Lisbon, Portugal with her husband, three sons, and a playful bernedoodle named Sally.

Licensed In: Virginia

Check out these blogs written by 

Rebecca Gwilt

Market Strategy
December 16, 2025
From Pilot to Purchase Order: Turn Validation into Scalable Contracts (Without Tripping Compliance)
This is the final piece in a three-part series on selling, scaling, and succeeding in healthcare—distilled from the class I teach at Texas Medical Center Innovation, Plug and Play, TechStars, and accelerators nationwide. In Part 1, we mapped healthcare's multi-actor buying process and positioned around outcomes that matter. In Part 2, we designed revenue models that align incentives and survive compliance using a five-step framework.
Market Strategy
November 28, 2025
Revenue Models That Actually Close in Healthcare: A 5-Step Framework That Aligns Incentives
This is the second in a three-part series on selling, scaling, and succeeding in healthcare—distilled from the class I teach at Texas Medical Center Innovation, Plug and Play, TechStars, and other accelerators nationwide.
Market Strategy
November 25, 2025
Stop Pitching. Start Helping: Selling Into Healthcare When Everyone Can Say “No”
This is the first in a three-part series on selling, scaling, and succeeding in healthcare—distilled from the class I teach at Texas Medical Center Innovation, Plug and Play, TechStars, and accelerators nationwide. Over the last decade, I've watched brilliant founders with game-changing products get stuck in healthcare's buying maze, not because their technology wasn't ready, but because their go-to-market wasn't.
Legal + Regulatory
November 17, 2025
The CPOM Crackdown: Why Telemedicine Startups Should Be Watching State Laws Closely
"Wait—so our MSO model might not be legal in Oregon anymore?" That’s the question a founder of a multi-state telehealth platform asked after Oregon passed SB 951. And she wasn’t alone. Across boardrooms and VC Slack channels, healthcare operators are scrambling to decode a fast-moving regulatory trend: a nationwide wave of Corporate Practice of Medicine (CPOM) legislation.
AI + Health Tech
July 28, 2025
How America’s AI Action Plan Opens New Regulatory Flexibility for Digital Health Innovators
With the recent unveiling of America’s AI Action Plan, the U.S. government is putting AI innovation at the center of its economic, defense, and technological strategy. While the plan is geared toward government execution, its ripple effects for the private sector—especially digital health companies—are undeniable.
Legal + Regulatory
July 10, 2025
“So... Can We Still Use Meta Pixel?” Health Marketing After GoodRx, BetterHelp & the AHA (Partial) Victory
The CMO of a national telehealth network is excited. “We finally have a campaign people love—targeted content based on condition pages users visited. Can we scale it?”Her privacy officer winces. “Well... it depends. Did the user log in? Submit anything? Or just browse?”“No login. It’s our main web page. They just submit a form requesting more information,” the CMO replies. “All we have is an email address.”“Okay. Then maybe. But we’re still in that weird limbo thanks to OCR’s pixel guidance... even after the AHA lawsuit.”And just like that, the campaign’s on hold again.